HomeCompareMDT vs WIT

MDT vs WIT: Dividend Comparison 2026

MDT yields 3.31% · WIT yields 5.59%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 WIT wins by $11606.50M in total portfolio value
10 years
MDT
MDT
● Live price
3.31%
Share price
$85.74
Annual div
$2.84
5Y div CAGR
29.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$54.3K
Annual income
$9,789.15
Full MDT calculator →
WIT
WIT
● Live price
5.59%
Share price
$2.07
Annual div
$0.12
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$11606.55M
Annual income
$11,220,668,219.46
Full WIT calculator →

Portfolio growth — MDT vs WIT

📍 WIT pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodMDTWIT
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, MDT + WIT cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
MDT pays
WIT pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MDT
Annual income on $10K today (after 15% tax)
$281.55/yr
After 10yr DRIP, annual income (after tax)
$8,320.78/yr
WIT
Annual income on $10K today (after 15% tax)
$474.81/yr
After 10yr DRIP, annual income (after tax)
$9,537,567,986.54/yr
At 15% tax rate, WIT beats the other by $9,537,559,665.76/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MDT + WIT for your $10,000?

MDT: 50%WIT: 50%
100% WIT50/50100% MDT
Portfolio after 10yr
$5803.30M
Annual income
$5,610,339,004.31/yr
Blended yield
96.67%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MDT right now

MDT
Analyst Ratings
1
Strong
26
Buy
22
Hold
Consensus: Buy
Price Target
$111.45
+30.0% upside vs current
Range: $100.00 — $120.00
Altman Z
2.9
Piotroski
7/9
WIT
Analyst Ratings
4
Buy
10
Hold
7
Sell
Consensus: Hold
Price Target
$7.35
+255.1% upside vs current
Range: $7.00 — $7.70
Altman Z
4.6
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MDT buys
0
WIT buys
0
No recent congressional trades found for MDT or WIT in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricMDTWIT
Forward yield3.31%5.59%
Annual dividend / share$2.84$0.12
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR29.3%100%
Portfolio after 10y$54.3K$11606.55M
Annual income after 10y$9,789.15$11,220,668,219.46
Total dividends collected$29.9K$11579.69M
Payment frequencyquarterlyquarterly
SectorHealthcareStock
Analyst consensusBuyHold
Analyst price target$111.45$7.35

Year-by-year: MDT vs WIT ($10,000, DRIP)

YearMDT PortfolioMDT Income/yrWIT PortfolioWIT Income/yrGap
1← crossover$11,128$428.29$11,817$1,117.20$689.00WIT
2$12,483$575.94$15,112$2,467.69$2.6KWIT
3$14,138$780.71$22,069$5,898.58$7.9KWIT
4$16,196$1,068.46$39,714$16,100.60$23.5KWIT
5$18,809$1,479.09$96,651$54,157.39$77.8KWIT
6$22,201$2,075.70$349,776$246,359.23$327.6KWIT
7$26,716$2,960.69$2,040,731$1,666,470.39$2.01MWIT
8$32,891$4,305.30$20,357,117$18,173,535.39$20.32MWIT
9$41,599$6,405.16$360,638,911$338,856,795.79$360.60MWIT
10$54,300$9,789.15$11,606,551,855$11,220,668,219.46$11606.50MWIT

MDT vs WIT: Complete Analysis 2026

MDTHealthcare

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and products. The company's Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure, electrosurgery products, surgical artificial intelligence and robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology and lung products, and various therapies to treat diseases, as well as products in the fields of minimally invasive gastrointestinal and hepatologic diagnostics and therapies, patient monitoring, airway management and ventilation therapies, and renal disease. Its Neuroscience Portfolio segment offers products for spinal surgeons; neurosurgeons; neurologists; pain management specialists; anesthesiologists; orthopedic surgeons; urologists; urogynecologists; interventional radiologists; ear, nose, and throat specialists; and systems that incorporate energy surgical instruments. It also provides image-guided surgery and intra-operative imaging systems and robotic guidance systems used in robot assisted spine procedures; and therapies for vasculature in and around the brain. The company's Diabetes Operating Unit segment offers insulin pumps and consumables, continuous glucose monitoring systems, smart insulin pen systems, and consumables and supplies. The company was founded in 1949 and is headquartered in Dublin, Ireland.

Full MDT Calculator →

WITStock

Wipro Limited operates as information technology (IT), consulting, and business process services company worldwide. It operates through three segments: IT Services, IT Products, and India State Run Enterprise Services (ISRE). The IT Services segment offers IT and IT-enabled services, including digital strategy advisory, customer-centric design, technology and IT consulting, custom application design, development, re-engineering and maintenance, systems integration, package implementation, cloud and infrastructure, business process, cloud, mobility and analytics, research and development, and hardware and software design services to enterprises. It serves customers in various industry sectors, such as healthcare and medical devices, consumer goods and life sciences, retail, transportation and services, communications, media and information services, technology products and platforms, banking, financial services and insurance, manufacturing, hi-tech, energy, and utilities. The IT Products segment provides a range of third-party IT products comprising enterprise platforms, networking solutions, software and data storage products, contact center infrastructure, enterprise security, IT optimization technologies, video solutions, and end-user computing solutions. It serves enterprises in various industries primarily in the India market, which comprise the government, defense, IT and IT-enabled services, telecommunications, manufacturing, utilities, education, and financial services sectors. The ISRE segment offers IT services to entities and departments owned or controlled by the Government of India and/or various Indian State Governments. The company was incorporated in 1945 and is based in Bengaluru, India.

Full WIT Calculator →
📬

Get this MDT vs WIT comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MDT vs SCHDMDT vs JEPIMDT vs OMDT vs KOMDT vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.